Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Traws Pharma, Inc. Common Stock (TRAW).
- Disclosed ownership: 20%.
- Date of event: 31 Dec 2024.
ORBIMED ADVISORS LLC - 31 Dec 2024 SCHEDULE 13D/A Report for Traws Pharma, Inc. Common Stock (TRAW)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Security
- Traws Pharma, Inc. Common Stock
- Symbol
- TRAW
- Shares outstanding
- 3,823,236 shares
- Disclosed Ownership
- 760,824 shares
- Ownership
- 20%
- Form type
- SCHEDULE 13D/A
- Filing time
- 29 Jan 2025, 18:42:44 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 20% ownership in Traws Pharma, Inc. Common Stock (TRAW) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Jan 2025, 18:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 20% | 760,824 | 0 | 760,824 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| OrbiMed Capital GP VIII LLC | 20% | 760,824 | 0 | 760,824 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001845804 |